IPCA Laboratories Ltd
NSE:IPCALAB

Watchlist Manager
IPCA Laboratories Ltd Logo
IPCA Laboratories Ltd
NSE:IPCALAB
Watchlist
Price: 1 591.35 INR 1.13% Market Closed
Market Cap: 403.7B INR
Have any thoughts about
IPCA Laboratories Ltd?
Write Note

Relative Value

The Relative Value of one IPCALAB stock under the Base Case scenario is 1 760.24 INR. Compared to the current market price of 1 591.35 INR, IPCA Laboratories Ltd is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IPCALAB Relative Value
Base Case
1 760.24 INR
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
17
vs Industry
31
Median 3Y
4
Median 5Y
4.1
Industry
2.5
Forward
4.4
vs History
1
vs Industry
7
Median 3Y
40.8
Median 5Y
31.6
Industry
21.9
Forward
44.3
vs History
6
vs Industry
15
Median 3Y
30.4
Median 5Y
28.8
Industry
16.5
vs History
1
vs Industry
3
Median 3Y
33.6
Median 5Y
39.6
Industry
23.6
vs History
11
vs Industry
15
Median 3Y
4.6
Median 5Y
4.8
Industry
2.1
vs History
12
vs Industry
30
Median 3Y
3.9
Median 5Y
4.1
Industry
2.6
Forward
4.4
vs History
17
vs Industry
35
Median 3Y
6.1
Median 5Y
6.4
Industry
5.2
vs History
1
vs Industry
16
Median 3Y
21.3
Median 5Y
20.1
Industry
13.3
Forward
23.6
vs History
1
vs Industry
13
Median 3Y
27.5
Median 5Y
24.1
Industry
16.6
Forward
30.6
vs History
6
vs Industry
14
Median 3Y
29.1
Median 5Y
28.1
Industry
15.6
vs History
39
vs Industry
9
Median 3Y
66.6
Median 5Y
62.8
Industry
19.1
vs History
44
vs Industry
25
Median 3Y
3.6
Median 5Y
3.9
Industry
1.9

Multiples Across Competitors

IPCALAB Competitors Multiples
IPCA Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
IPCA Laboratories Ltd
NSE:IPCALAB
403.7B INR 4.9 70 29.7 40.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
IPCA Laboratories Ltd
NSE:IPCALAB
Average P/E: 37.1
70
169%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top